Clinical trial
Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus…
NCT00192205 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192205 |
|---|---|
| Title | Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children |
| Official title | A Prospective, Randomized, Open-Label, Controlled Trial to Compare the Safety, Tolerability and Efficacy of Influenza Virus Vaccine, Trivalent, Type A&B, Live, Cold-Adapted (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children With a History of Recurrent Respiratory Tract… |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Tract Infections |
| Intervention type | Biological |
| Interventions | CAIV-T or TIV |
| Enrollment | 2,200 |
| Start date | Oct 1, 2002 |
| Completion | Jun 1, 2003 |
| First posted | Sep 19, 2005 |
| Last update posted | Oct 3, 2006 |
| Countries | Israel, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: